Clinical Report: Lung cancer deaths plunge as survival doubles

Overview

The Annual Report to the Nation on the Status of Cancer indicates significant declines in lung cancer mortality, with rates decreasing 4.7% per year among males and 3% among females. The five-year relative survival rate for lung cancer has doubled from 15% in 2000 to 30% in 2018.

Background

Lung cancer remains the leading cause of cancer-related deaths in the United States. The report highlights a decline in lung cancer incidence and mortality, driven by reductions in smoking and increased screening.

Data Highlights

Key Findings

• Lung cancer mortality decreased by 52% among males and 37% among females from 2004 to 2023.
• The proportion of lung cancers diagnosed at a localized stage increased from 16% to 27% among males and from 19% to 33% among females from 2003 to 2022.
• Five-year relative survival for lung cancer doubled from 15% in 2000 to 30% in 2018.
• Adult cigarette smoking prevalence declined by 56% from 2001 to 2024.
• Screening uptake among eligible adults increased from 4.5% in 2015 to 18.7% in 2024.

Clinical Implications

Healthcare professionals should prioritize tobacco cessation efforts and promote lung cancer screening to sustain the progress observed in lung cancer outcomes. Understanding the demographic variations in lung cancer incidence can aid in targeted interventions.

Related Resources & Content

1. Annual Report to the Nation, Cancer, 2023 -- Lung cancer deaths plunge as survival doubles
2. the asco post — New Report: Lung Cancer Advancements Are Saving More Lives Than Ever, but Funding Cuts May Hinder Progress
3. the asco post — Record Drop in Cancer Mortality for Second Straight Year Due to Improved Lung Cancer Treatment Reported in ‘Cancer Statistics, 2021’
4. the asco post — ACS Report Shows 5-Year Survival for All Cancers Combined Has Reached 70%
5. The ASCO Post — Annual Report to the Nation: Cancer Death Rates Continue to Decline Key Points
6. New Report: Lung Cancer Advancements Are Saving More Lives Than Ever, but Funding Cuts May Hinder Progress
7. Record Drop in Cancer Mortality for Second Straight Year Due to Improved Lung Cancer Treatment Reported in ‘Cancer Statistics, 2021’
8. ACS Report Shows 5-Year Survival for All Cancers Combined Has Reached 70%
9. Annual Report to the Nation - NCI
10. Screening for lung cancer: 2023 guideline update from the American Cancer Society - Wolf - 2024 - CA: A Cancer Journal for Clinicians - Wiley Online Library
11. Therapy for Stage IV Non–Small Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline, 2026.3.0